Elicio Therapeutics, Inc. (ELTX): Total Assets
$25.86M
As of 2025-12-31
$31.33M
As of 2026-06-30
+4.5%
3-year compound annual growth
-11.4%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $25.86M | -8.2% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $28.18M | +3.8% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $27.15M | +19.8% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $22.66M | -76.5% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $96.51M | +103.8% | 2023-03-17, Balance as of period end |
| 2020-12-31 | $47.35M | n/a | 2022-03-30, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Elicio Therapeutics, Inc. (ELTX) | 2025-12-31 | $25.86M | -8.2% |
| BeyondSpring Inc. (BYSI) | 2025-12-31 | $25.93M | -24.4% |
| CASI Pharmaceuticals, Inc. (CASIF) | 2025-12-31 | $25.65M | -52.2% |
| Integrated Biopharma Inc (INBP) | 2026-06-30 | $25.34M | +1.8% |
| Onconetix, Inc. (ONCO) | 2025-12-31 | $24.93M | -11.5% |
| Aptevo Therapeutics Inc. (APVO) | 2025-12-31 | $27.19M | +74.4% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $24.52M | -18.9% |
| TuHURA Biosciences, Inc. (HURA) | 2025-12-31 | $27.35M | +37.0% |
| Kiora Pharmaceuticals Inc (KPRX) | 2025-12-31 | $24.25M | -33.5% |
Compare ELTX, BYSI, CASIF, INBP side by side · Screen every company in Pharmaceutical Preparations ↗